Saninova tablets in fasting healthy adults
This trial studies how the body processes a new vitamin-like tablet (Saninova) when taken without food. It helps determine the right dosage and ensures it is safe for healthy people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old and weigh at least 110 pounds (50 kg).
- Your body mass index (BMI) is between 18.5 and 30.
- You are a non-smoker and do not drink alcohol.
- You are in good health, with no major medical conditions or chronic illnesses.
- Women must not be pregnant, breastfeeding, or use certain hormonal contraceptives; they must use birth control or have been post-menopausal for at least a year.
- You must avoid donating blood, taking other medications or supplements, and drinking tea or coffee excessively during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.
This study tests a new slow-release tablet (Hemay5259) in healthy people. It aims to check how safe the drug is, how it works in the body, and whether food changes its effects. Participants will receive the drug and be closely monitored for side effects.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
This early-phase trial tests a new drug, SYH2056, in healthy people to see how safe it is and how the body handles it. The study will also look at how food affects the drug. If you are generally healthy, this could be a way to contribute to medical research.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
Hear when a new Bioavailability and Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.